Additional Advances in Waldenstrom Macroglobulinemia Research and Clinical Trials: Morie Gertz, MD episode artwork

EPISODE · Nov 22, 2022 · 5 MIN

Additional Advances in Waldenstrom Macroglobulinemia Research and Clinical Trials: Morie Gertz, MD

from Oncology Data Advisor · host i3 Health

In January 2022, Dr. Morie Gertz, Professor and Chair of General Internal Medicine at the May Clinic in Minnesota, served as faculty for the Waldenstrom macroglobulinemia (WM) session of the Oncology Data AdvisorTM Hematologic Malignancies Symposium. With several significant updates in the treatment and management of WM since then, Dr. Gertz sat down with Oncology Data Advisor again to share all that has occurred in this evolving field.

Episode metadata supplied by the publisher feed · Published Nov 22, 2022

Embed this episode

NOW PLAYING

Additional Advances in Waldenstrom Macroglobulinemia Research and Clinical Trials: Morie Gertz, MD

0:00 5:05

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

No similar episodes found.

No similar podcasts found.

Frequently Asked Questions

How long is this episode of Oncology Data Advisor?

This episode is 5 minutes long.

When was this Oncology Data Advisor episode published?

This episode was published on November 22, 2022.

Can I download this Oncology Data Advisor episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.
URL copied to clipboard!